Literature DB >> 17999098

Ion-channels on parasite muscle: pharmacology and physiology.

Alan P Robertson1, Richard J Martin.   

Abstract

Ion-channels are essential components of excitable cells. This fact has been exploited in the development of anthelmintic agents; the majority of which act on nematode ion channels. The purpose of this review is to describe the site of action of some frequently used anthelmintic compounds: nAChRs and levamisole/pyrantel; Glu-Cls and avermectins/mylbemycins; GABA receptors and piperazine. Also described is some of the physiological and pharmacological data on other nematode muscle ion-channels which may prove attractive targets for future anthelmintic development: Ca2+ activated Cl(-) channels; peptide gated chloride Cl(-) channels; Ca2+ channels and potassium channels. Emphasis is placed on the pharmacological and physiological data from parasite tissue. Information on the genes involved in ion-channel formation and modulation are reviewed in detail elsewhere in this issue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999098     DOI: 10.1007/s10158-007-0059-x

Source DB:  PubMed          Journal:  Invert Neurosci        ISSN: 1354-2516


  54 in total

1.  One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction.

Authors:  J E Richmond; E M Jorgensen
Journal:  Nat Neurosci       Date:  1999-09       Impact factor: 24.884

Review 2.  Structure and regulation of voltage-gated Ca2+ channels.

Authors:  W A Catterall
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

Review 3.  Neuropeptide signaling systems - potential drug targets for parasite and pest control.

Authors:  Aaron G Maule; Angela Mousley; Nikki J Marks; Tim A Day; David P Thompson; Timothy G Geary; David W Halton
Journal:  Curr Top Med Chem       Date:  2002-07       Impact factor: 3.295

4.  The nematode neuropeptide, AF2 (KHEYLRF-NH2), increases voltage-activated calcium currents in Ascaris suum muscle.

Authors:  S Verma; A P Robertson; R J Martin
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

Review 5.  Costs of major parasites to the Australian livestock industries.

Authors:  R S McLeod
Journal:  Int J Parasitol       Date:  1995-11       Impact factor: 3.981

6.  gamma-Aminobutyric acid- and piperazine-activated single-channel currents from Ascaris suum body muscle.

Authors:  R J Martin
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

7.  GABA receptors on the somatic muscle cells of the parasitic nematode, Ascaris suum: stereoselectivity indicates similarity to a GABAA-type agonist recognition site.

Authors:  L Holden-Dye; P Krogsgaard-Larsen; L Nielsen; R J Walker
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

8.  Levamisole-activated single-channel currents from muscle of the nematode parasite Ascaris suum.

Authors:  S J Robertson; R J Martin
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

9.  A patch-clamp study of effects of dihydroavermectin on Ascaris muscle.

Authors:  R J Martin; A J Pennington
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

10.  Voltage-activated currents in somatic muscle of the nematode parasite Ascaris suum.

Authors:  R J Martin; P Thorn; K A Gration; I D Harrow
Journal:  J Exp Biol       Date:  1992-12       Impact factor: 3.312

View more
  18 in total

Review 1.  Genome mining offers a new starting point for parasitology research.

Authors:  Zhiyue Lv; Zhongdao Wu; Limei Zhang; Pengyu Ji; Yifeng Cai; Shiqi Luo; Hongxi Wang; Hao Li
Journal:  Parasitol Res       Date:  2015-01-08       Impact factor: 2.289

2.  The genome of the hydatid tapeworm Echinococcus granulosus.

Authors:  Huajun Zheng; Wenbao Zhang; Liang Zhang; Zhuangzhi Zhang; Jun Li; Gang Lu; Yongqiang Zhu; Yuezhu Wang; Yin Huang; Jing Liu; Hui Kang; Jie Chen; Lijun Wang; Aojun Chen; Shuting Yu; Zhengchao Gao; Lei Jin; Wenyi Gu; Zhiqin Wang; Li Zhao; Baoxin Shi; Hao Wen; Renyong Lin; Malcolm K Jones; Brona Brejova; Tomas Vinar; Guoping Zhao; Donald P McManus; Zhu Chen; Yan Zhou; Shengyue Wang
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

3.  Calcium channels of schistosomes: unresolved questions and unexpected answers.

Authors:  Vicenta Salvador-Recatalà; Robert M Greenberg
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012

4.  Functional genomics in Brugia malayi reveal diverse muscle nAChRs and differences between cholinergic anthelmintics.

Authors:  Saurabh Verma; Sudhanva Srinivas Kashyap; Alan Patrick Robertson; Richard John Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-09       Impact factor: 11.205

5.  Ion channels and drug transporters as targets for anthelmintics.

Authors:  Robert M Greenberg
Journal:  Curr Clin Microbiol Rep       Date:  2014-12

Review 6.  Current drug targets for helminthic diseases.

Authors:  Ajay Kumar Rana; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2013-03-26       Impact factor: 2.289

7.  Levamisole and ryanodine receptors. II: An electrophysiological study in Ascaris suum.

Authors:  Sreekanth Puttachary; Alan P Robertson; Cheryl L Clark; Richard J Martin
Journal:  Mol Biochem Parasitol       Date:  2010-01-11       Impact factor: 1.759

8.  Electrophysiological recording from parasitic nematode muscle.

Authors:  Alan P Robertson; Sreekanth Puttachary; Samuel K Buxton; Richard J Martin
Journal:  Invert Neurosci       Date:  2008-11-13

9.  Evidence for Novel Pharmacological Sensitivities of Transient Receptor Potential (TRP) Channels in Schistosoma mansoni.

Authors:  Swarna Bais; Matthew A Churgin; Christopher Fang-Yen; Robert M Greenberg
Journal:  PLoS Negl Trop Dis       Date:  2015-12-11

10.  Functional characterization of a novel family of acetylcholine-gated chloride channels in Schistosoma mansoni.

Authors:  Kevin MacDonald; Samuel Buxton; Michael J Kimber; Tim A Day; Alan P Robertson; Paula Ribeiro
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.